Blocking type I interferon (IFN) signaling impairs antigen responsiveness of circulating lymphocytes and alters their homing to lymphoid organs : protective role of type I IFN
Copyright © 2010 S. Karger AG, Basel..
BACKGROUND: We recently demonstrated that type I Interferon (IFN) rescues in vitro, human B-lymphocytes from apoptosis via PI3Kδ/Akt, Rho-A, NFκB and Bcl-2/BclXL. In the present study we extended our work to clarify, in vivo, the role of type I IFN signalling on the circulating and lymphoid organs homing lymphocytes.
METHODOLOGY: Two groups of mice 13 in each were set: type I IFN signalling blocked mice injected with anti-IFNAR1 antagonist antibody (10 mg/kg body weight) once/day for up to 20 days, and control group were injected with vehicle alone.
RESULTS: Flow cytometry analysis to monitor the blood lymphocyte phenotype and proliferation have shown a significant decrease in CD45R/B220(+) [corrected] B cells, CD4(+) and CD8(+) T cells in treated animals. Furthermore, the proliferative capacities of these lymphocyte subsets were significantly decreased in treated animals compared to those of control mice. Marked reduction in the plasma levels of IL-2 and IL-7 (cytokines important for the development of T and B cells) but not of IL-6 or IL-10 was observed in treated mice and this may a cause for emergence decrease in B and T cell numbers. Immunohistochemical studies have further shown a marked reduction in the numbers of CD20(+) B cells in spleen and Peyer's patches and CD3(+) T cells in thymus of treated animals. Moreover, electron microscopy examinations have revealed a loss of lymphocytes with characteristic features of apoptosis.
CONCLUSION: Our data confirmed that the in vivo inhibition of type I IFN signaling induce decrease in the numbers and defective functions of circulating and lymphoid organs homing lymphocytes providing a strong evidence for the protective effects of type 1 IFNs (IFN-α/β) on B and T lymphocytes.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology - 26(2010), 6 vom: 07., Seite 1029-40 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Badr, Gamal [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
130068-27-8 |
|---|
| Anmerkungen: |
Date Completed 21.04.2011 Date Revised 12.02.2019 published: Print-Electronic ErratumIn: Cell Physiol Biochem. 2011;27(1):I Citation Status MEDLINE |
|---|
| doi: |
10.1159/000323978 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM204932211 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM204932211 | ||
| 003 | DE-627 | ||
| 005 | 20231223232952.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231223s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000323978 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0683.xml |
| 035 | |a (DE-627)NLM204932211 | ||
| 035 | |a (NLM)21220934 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Badr, Gamal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Blocking type I interferon (IFN) signaling impairs antigen responsiveness of circulating lymphocytes and alters their homing to lymphoid organs |b protective role of type I IFN |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.04.2011 | ||
| 500 | |a Date Revised 12.02.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Cell Physiol Biochem. 2011;27(1):I | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2010 S. Karger AG, Basel. | ||
| 520 | |a BACKGROUND: We recently demonstrated that type I Interferon (IFN) rescues in vitro, human B-lymphocytes from apoptosis via PI3Kδ/Akt, Rho-A, NFκB and Bcl-2/BclXL. In the present study we extended our work to clarify, in vivo, the role of type I IFN signalling on the circulating and lymphoid organs homing lymphocytes | ||
| 520 | |a METHODOLOGY: Two groups of mice 13 in each were set: type I IFN signalling blocked mice injected with anti-IFNAR1 antagonist antibody (10 mg/kg body weight) once/day for up to 20 days, and control group were injected with vehicle alone | ||
| 520 | |a RESULTS: Flow cytometry analysis to monitor the blood lymphocyte phenotype and proliferation have shown a significant decrease in CD45R/B220(+) [corrected] B cells, CD4(+) and CD8(+) T cells in treated animals. Furthermore, the proliferative capacities of these lymphocyte subsets were significantly decreased in treated animals compared to those of control mice. Marked reduction in the plasma levels of IL-2 and IL-7 (cytokines important for the development of T and B cells) but not of IL-6 or IL-10 was observed in treated mice and this may a cause for emergence decrease in B and T cell numbers. Immunohistochemical studies have further shown a marked reduction in the numbers of CD20(+) B cells in spleen and Peyer's patches and CD3(+) T cells in thymus of treated animals. Moreover, electron microscopy examinations have revealed a loss of lymphocytes with characteristic features of apoptosis | ||
| 520 | |a CONCLUSION: Our data confirmed that the in vivo inhibition of type I IFN signaling induce decrease in the numbers and defective functions of circulating and lymphoid organs homing lymphocytes providing a strong evidence for the protective effects of type 1 IFNs (IFN-α/β) on B and T lymphocytes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Antibodies |2 NLM | |
| 650 | 7 | |a Antigens |2 NLM | |
| 650 | 7 | |a Interferon Type I |2 NLM | |
| 650 | 7 | |a Interleukin-2 |2 NLM | |
| 650 | 7 | |a Interleukin-6 |2 NLM | |
| 650 | 7 | |a Interleukin-7 |2 NLM | |
| 650 | 7 | |a Interleukin-10 |2 NLM | |
| 650 | 7 | |a 130068-27-8 |2 NLM | |
| 700 | 1 | |a Waly, Hanan |e verfasserin |4 aut | |
| 700 | 1 | |a Eldien, Heba M Saad |e verfasserin |4 aut | |
| 700 | 1 | |a Abdel-Tawab, Hanem |e verfasserin |4 aut | |
| 700 | 1 | |a Hassan, Khadega |e verfasserin |4 aut | |
| 700 | 1 | |a Alhazza, Ibrahim M |e verfasserin |4 aut | |
| 700 | 1 | |a Ebaid, Hossam |e verfasserin |4 aut | |
| 700 | 1 | |a Alwasel, Saleh H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology |d 1996 |g 26(2010), 6 vom: 07., Seite 1029-40 |w (DE-627)NLM090692519 |x 1421-9778 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2010 |g number:6 |g day:07 |g pages:1029-40 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1159/000323978 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2010 |e 6 |b 07 |h 1029-40 | ||